Spero Therapeutics (SPRO) Assets (2016 - 2026)
Spero Therapeutics (SPRO) posted Assets of $52.77 million for Q2 2026, down 15.1% from $62.12 million a year earlier and down 10.6% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Spero Therapeutics' Assets came in at $68.92 million, down 37.7% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of -14.8% (FY2020 to FY2025).
- In prior years, Spero Therapeutics' Assets was $110.54 million in FY2024 (-39.4%), $182.39 million in FY2023 (+46.1%), $124.8 million in FY2022 (-27.0%) and $171.07 million in FY2021 (+11.5%).
- The Q2 2026 figure stands as the lowest quarterly Assets since Q3 2017.
- On a year-over-year basis, Assets has declined in each of the last seven quarters, with an average decline of 32.8% over the last eight quarters.
- The strongest year-over-year quarter for Assets in the past five years was Q3 2023, with growth of 66.1%; the weakest was Q3 2025, with a decline of 59.9%.
- According to Business Quant data, Assets for the three prior quarters was $59.02 million (Q1 2026), $68.92 million (Q4 2025) and $54.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 119.92 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Spero Therapeutics | 58.73 Mn | -137.06 Mn | - | 52.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52.77 Mn |
| Mar 31, 2026 | 59.02 Mn |
| Dec 31, 2025 | 68.92 Mn |
| Sep 30, 2025 | 54.17 Mn |
| Jun 30, 2025 | 62.12 Mn |
| Mar 31, 2025 | 77.71 Mn |
| Dec 31, 2024 | 110.54 Mn |
| Sep 30, 2024 | 135.16 Mn |
| Jun 30, 2024 | 149.88 Mn |
| Mar 31, 2024 | 167.70 Mn |
| Dec 31, 2023 | 182.39 Mn |
| Sep 30, 2023 | 107.10 Mn |
| Jun 30, 2023 | 98.89 Mn |
| Mar 31, 2023 | 112.55 Mn |
| Dec 31, 2022 | 124.80 Mn |
| Sep 30, 2022 | 64.48 Mn |
| Jun 30, 2022 | 63.63 Mn |
| Mar 31, 2022 | 145.83 Mn |
| Dec 31, 2021 | 171.07 Mn |
| Sep 30, 2021 | 144.69 Mn |
API Access
Spero Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();